Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2004

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
The aim of the study is to assess the short-term benefit of the combination of basiliximab, EC-MPS and cyclosporine microemulsion with C2 monitoring on the prophylaxis of acute rejection in a population of de novo renal transplant patients at potential high risk of DGF.
Epistemonikos ID: 62b833605db2ab435e0b5f5b5058c4643c333e4a
First added on: May 04, 2024